BAWCOMBE, DREW MD
Ophthalmology · NPI 1801004932 · DEERFIELD BEACH, FL
BAWCOMBE, DREW is a Ophthalmology in DEERFIELD BEACH, FL, a member of 5 medical groups, who billed 17 distinct codes to Medicare Part B in 2024.
Groups: ARAN EYE ASSOCIATES PA (CORAL GABLES, FL) · DRS AIRALA LASER AND CATARACT INSTITUTE PA (MIAMI, FL) · EYE PHYSICIANS OF FLORIDA LLP (PLANTATION, FL) · FLORIDA EYE AND PLASTIC SURGERY ASSOCIATES INC (BOYNTON BEACH, FL) · SPECIALTY RETINA CENTER, LLC (BOCA RATON, FL) — member of 5 groups; the volumes below are this clinician's personal volume and are not attributed to any single group
Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒
Provider overview · all codes · CY2024
All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.
Procedures billed to Medicare Part B (2024)
Medicare Part B FFS · CY2024 · as published by CMS| Code | Description | Services | Beneficiary-episodes | Avg charge | Avg Medicare payment |
|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | premium | premium | premium | premium |
| 92134 | Imaging of retina | premium | premium | premium | premium |
| 67028 | Injection of drug into eye | premium | premium | premium | premium |
| J0178 | Injection, aflibercept, 1 mg | premium | premium | premium | premium |
| 92014 | Established patient complete exam of visual system | premium | premium | premium | premium |
| J7999 | Compounded drug, not otherwise classified | premium | premium | premium | premium |
| 92250 | Photography of the retina | premium | premium | premium | premium |
| 76512 | 2d ultrasound scan of eye tissue and structures | premium | premium | premium | premium |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | premium | premium | premium | premium |
| J3490 | Unclassified drugs | premium | premium | premium | premium |
| 92012 | Established patient problem focused exam of visual system | premium | premium | premium | premium |
| J9999 | Not otherwise classified, antineoplastic drugs | premium | premium | premium | premium |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | premium | premium | premium | premium |
| J9035 | Injection, bevacizumab, 10 mg | premium | premium | premium | premium |
| 92242 | Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye | premium | premium | premium | premium |
| 92004 | New patient complete exam of visual system | premium | premium | premium | premium |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | premium | premium | premium | premium |
These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.